Webinar

Akkermansia and Other Novel Probiotic Strains to Address the Microbiome and Metabolic Health

Speakers

Alex Keller, ND

Colleen Cutcliffe, PhD

Jeff Gladd, MD

42 minutes

Sign up for Academy to watch

Gain access to evolving research into evidence-based education that supports streamlined whole person care.

Create account

About this webinar

Join Fullscript’s Chief Medical Officer, Jeff Gladd, MD, and Medical Director, Alex Keller, ND, as they discuss novel microbiome interventions for metabolic health with Pendulum’s Chief Executive Officer, Colleen Cutcliffe, Ph.D.

Key takeaways

Overview of the prevalence of metabolic syndrome and the gut-metabolism axis
Discussion of five evidence-based probiotic strains shown to influence metabolic health
Brief discussion of evidence-based protocols to support gut and metabolic health

Partners

Pendulum

Speakers

Alex Keller, ND

Medical Director, Fullscript

Dr. Alex Keller is a licensed and practicing naturopathic doctor in Ottawa, Canada and the medical director at Fullscript.

Colleen Cutcliffe, PhD

CEO and Co-founder, Pendulum Therapeutics

Colleen Cutcliffe is the Chief Executive Officer and co-founder of Pendulum. She has more than 25 years of experience leading and managing biology teams in academia, pharmaceuticals, and biotechnology.

Jeff Gladd, MD

Chief Medical Officer, Fullscript

As Chief Medical Officer at Fullscript, Dr. Jeff Gladd advises on company and product direction with the perspective of integrative and family medicine.